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Kaposi’s sarcoma-associated herpesvirus (KSHV) is
linked to human malignancies. The majority of tumor
cells harbor latent virus, and a small percentage
undergo spontaneous lytic replication. Both latency
and lytic replication are important for viral pathogen-
esis and spread, but the cellular players involved in
the switch between the two viral life-cycle phases
are not clearly understood. We conducted a small
interfering RNA (siRNA) screen targeting the cellular
kinome and identified Tousled-like kinases (TLKs)
as cellular kinases that control KSHV reactiva-
tion from latency. Upon treatment of latent KSHV-
infected cells with siRNAs targeting TLKs, we saw
robust viral reactivation. Knockdown of TLKs in
latent KSHV-infected cells induced expression of
viral lytic proteins and production of infectious virus.
TLKswere also found to play a role in regulating reac-
tivation from latency of another related oncogenic
gammaherpesvirus, Epstein-Barr virus. Our results
establish the TLKs as cellular repressors of gamma-
herpesvirus reactivation.
INTRODUCTION
Kaposi’s sarcoma-associated herpesvirus (KSHV) is linked to
a number of human malignancies, including Kaposi’s sarcoma
(KS), primary effusion lymphoma (PEL), and multicentric
Castleman disease (MCD) (Chang et al., 1994, Songyang et al.,
1994; Stu¨rzl et al., 1997; Cesarman et al., 1995; Soulier et al.,
1995). In the majority of infected cells, KSHV remains latent;
however, a small percentage of cells can undergo spontaneous
lytic replication at any given time (Zhong et al., 1996; Poyet et al.,
2001). This low level of viral reactivation is believed to be impor-
tant for persistence and tumorigenesis (Grundhoff and Ganem,
2004). Both latency and lytic replication are important phases
for viral pathogenesis and spread, but the cellular players
involved in the switch between the two phases of the viral life
cycle are not clearly understood.204 Cell Host & Microbe 13, 204–214, February 13, 2013 ª2013 ElseIn cell culture, reactivation of KSHV occurs following treatment
with chemical compounds such as the phorbol ester 12-O-
tetradecanoyl-phorbol-13-acetate (TPA/PMA) and the histone
deacetylase inhibitor sodium butyrate. We previously reported
that activation of Toll-like receptors 7 and 8 in PEL cells led to
KSHV reactivation (Gregory et al., 2009). In an overexpression
system, using transient transfection of kinase complementary
DNAs (cDNAs), other investigators showed that both the Pim
and Ras family kinases are involved in KSHV reactivation (Cheng
et al., 2009; Yu et al., 2007).
To determine the cellular kinases that control KSHV reactiva-
tion from latency, we performed a small interfering RNA (siRNA)
screen of the cellular kinome in the absence of any chemical
inducers. This allowed us to assess which kinases are needed
for the virus to maintain latency or to induce reactivation. A
siRNA library containing siRNAs against 720 different human
kinases was used for the screen. We identified the Tousled-
like kinases (TLKs) as cellular kinases involved in reactivation
of KSHV.
Originally described in the plant Arabidopsis thaliana, the
Tousled gene encodes a nuclear serine/threonine kinase that is
essential for flower and leaf development (Roe et al., 1993,
1997). Two mammalian homologs, TLK1 and TLK2, show 84%
sequence similarity to each other (Takahata et al., 2009). The
TLKs are regulated by cell-cycle-dependent phosphorylation,
their activity is tightly linked to DNA replication with maximal
activity during S phase, and they are sensitive to DNA-damaging
agents and inhibitors of DNA replication (Takahata et al., 2009).
TLKs are also involved in chromatin assembly. TLK1 and TLK2
bind to and phosphorylate the human chromatin assembly
factors Asf1a and Asf1b (Sillje´ and Nigg, 2001). The TLKs have
been implicated in numerous replicative and transcriptional
processes, including chromosome condensation and segrega-
tion (Sunavala-Dossabhoy et al., 2003; Hashimoto et al., 2008),
gene silencing (Wang et al., 2007), and DNA repair (Sunavala-
Dossabhoy et al., 2005; Canfield et al., 2009).
In this study, we identified TLKs as modulators of KSHV reac-
tivation. Our results show that depletion of TLK2 in KSHV latently
infected epithelial cells leads to robust viral reactivation. Knock-
down of TLK2 induces ORF50/RTA activation, expression of viral
lyticmessenger RNA (mRNA) and proteins, and the production of
infectious progeny virions. Depletion of TLK2, and to a lesser
extent TLK1, also leads to KSHV viral reactivation from latentlyvier Inc.
Figure 1. Design of siRNA Screen and Analysis of Data
(A) Schematic of cellular kinome siRNA screen. siRNAs from the Dharmacon
SMARTpool kinase siRNA library were loaded into 384-well plates in triplicate.
KSHV-293 cells were added to each well containing siRNA and incubated for
70 hr at 37C. BothRFP andGFP imageswere then taken for five fields perwell.
(B) Control siRNAs demonstrate efficient siRNA transfection in our screen.
GAPDH and UBB siRNAs were reverse transfected at 25 nM each into 2,500
KSHV-293 cells/well in a 384-well plate. At 70 hr posttransfection, bright-field,
GFP, and RFP pictures were taken on a fluorescent microscope.
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Cell Host &infected B cells. Moreover, we found that knockdown of TLK1,
and to a lesser extent TLK2, results in reactivation of another
gammaherpesvirus family member, Epstein-Barr virus (EBV).
Our results indicate that the TLKs are key regulators of KSHV
and EBV reactivation, and their expression is required for the
maintenance of viral latency.
RESULTS
Cellular siRNA Kinome Screen
To determine which cellular kinases are important for KSHV re-
activation, we performed a siRNA screen targeting the human
cellular kinome. More than 720 siRNAs against all human protein
and lipid kinases were included in the screen. Each well con-
tained a pool of four siRNAs with different target sequences to
a single cellular kinase. For the screen, we used KSHV-infected
293 (KSHV-293) cells that harbor latent KSHV and constitutively
express green fluorescent protein (GFP), whereas red fluores-
cent protein (RFP) is under the control of a lytic promoter and
thus is only expressed upon viral reactivation (Vieira and
O’Hearn, 2004). A variety of confounding factors often lead to
high false-discovery rates in siRNA screens, which is an inevi-
table result of high-throughput investigations. To lessen the
false-discovery rate, we performed our primary screen in tripli-
cate and used robust statistical analysis. We reverse transfected
the cells with the siRNA pools, and 70 hr post-siRNA transfection
acquired GFP and RFP images and fluorescence intensities
using a Cellomics ArrayScan VTI HCS Reader (Figure 1A). To
ensure efficient siRNA transfection, an siRNA against Ubiquitin
B (UBB) was included as a control siRNA in the screen, because
UBB knockdown is known to lead to cell death (Tiedemann et al.,
2010; Figure 1B).We analyzed the siRNA screen data using the R
statistical program environment (http://www.R-project.org). We
determined statistically significant changes in viral reactivation
(i.e., RFP intensity) using both the median and mean RFP values
for all the wells of the siRNA screen. Figure 1C shows a waterfall
plot of the Z scores of the median RFP value for each of the
siRNAs. A Z score ofR2 was considered significant (Figure 1C).
Additionally, Table 1 lists the cellular kinases that when depleted
showed aR2 SD increase from the overall mean RFP intensity.
One isoform of TLK, TLK2, stood out in both of these analyses
(Figure 1C; Table 1) because knockdown of TLK2 showed a Z
score of 15 based on the median RFP value, and TLK2 knock-
down led to a level of RFP expression that was 13 SDs above
the mean RFP value for the screen. The next most significant
kinases were only 3 SDs above the mean. These comprised
seven out of 720 (1%) of the siRNA targets, attesting to the spec-
ificity and stringency of our screen. It is possible that some of the
siRNAs in our screen did not sufficiently deplete their target
protein and thus could potentially provide a false-negative result.
Except for the TLKs, we did not confirm any of the hits listed in
Table 1. Figure 1D shows representative GFP and RFP images(C) Statistical analysis of primary hits. A waterfall plot was used to analyze the
data acquired from the screen. It shows the Z score of the median RFP
intensity of each siRNA.
(D) Reactivation by TLK2 knockdown in KSHV-293 cells. GFP and RFP images
of a representative field taken during the screen are shown for the wells
containing siRNA targeting GAPDH, TLK1, and TLK2. See also Figure S1.
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Table 1. List of Transfected siRNAs that Yield Increased RFP
Intensities at Least 2 SDs from the Mean when Transfected into
KSHV-293 Cells
RFP Intensity 2 SD 3 SD 13 SD
TLK2 increased ++ ++ ++
ETNK1 increased ++ ++
STK17B increased ++ ++
FASTK increased ++ ++
MAP4K5 increased ++ ++
ATR increased ++ ++
EPHA4 increased ++ ++
LCK increased ++
CSNK1G1 increased ++
MAP3K7 increased ++
TNK2 increased ++
FN3K increased ++
PDK3 increased ++
DGKQ increased ++
PTK6 increased ++
GK increased ++
ABL1 increased ++
MAP3K7IP1 increased ++
KIAA1765 increased ++
DUSP21 increased ++
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knockdown of TLK1 shows no change in RFP expression
compared with the GAPDH siRNA control in KSHV-293 cells,
whereas TLK2 knockdown results in a large increase in RFP-
positive cells indicative of viral reactivation. To rule out the possi-
bility that viral reactivation following TLK2 knockdown is due to
off-target effects of one or more of the TLK2 siRNAs, we trans-
fected KSHV-293 cells with each of the four individual TLK2
siRNAs that target different regions of the TLK2 transcript. The
cells were examined bymicroscopy (Figure S1A available online)
and cell lysates were subjected to western blots (Figure S1B).
Three of the four siRNAs showed significant knockdown of
TLK2 and robust viral reactivation.
TLK2 Knockdown Leads to KSHV Reactivation
in KSHV-293 Cells
To validate our screen results, we reverse transfected KSHV-293
cells with equivalent amounts of glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) siRNA or a pool of four siRNAs against
TLK1 and TLK2. The cells were imaged at 70 hr posttransfection
for GFP and RFP expression, and again knockdown of TLK2
robustly induced RFP expression (Figure 2A). We also harvested
cell lysates and performed western blots to look at kinase
expression levels. As shown in Figure 2B, siRNA transfection
led to dramatic decreases in the expression of the target protein.
To validate this result, we also used a TLK2 siRNA from
a different source that targeted a different part of the TLK2
transcript and measured viral reactivation. We saw the same
reactivation phenotype as described above (Figures S2A and
S2B). To determine whether TLK2 levels were increased in
KSHV-293 latently infected cells compared with uninfected cells,206 Cell Host & Microbe 13, 204–214, February 13, 2013 ª2013 Elsewe performed western blots probing for TLK2, and found that
expression levels of TLK2 were similar between infected and
uninfected cells (Figure S2C). We also tested whether knock-
down of TLK2 affected the cell viability of HEK293 cells in the
absence of KSHV. We transfected 293 cells with a nontargeting
control (NTC) siRNA or siRNAs against TLK2 or UBB, and exam-
ined them by microscopy at 72 hr to gauge viability (Figure S2D).
TLK2 knockdown had only aminor effect on cell viability, and cell
death in the TLK2 knockdown cells was similar to that in the NTC
siRNA transfected control cells and much less pronounced than
that in the positive control cells transfected with UBB siRNA.
We also examined the effect of TLK2 knockdown on HEK293
cell proliferation using a 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner
salt (MTS) assay, and found that TLK2 knockdown did not cause
an overall loss in proliferation as was seen following UBB knock-
down over the time period examined (Figure S2E).
Depletion of TLK2 Leads to Expression of KSHV Lytic
Genes
To determine whether TLK2 knockdown resulted in increased
viral lytic gene expression, we transfected KSHV-293 cells with
an NTC siRNA or siRNAs against TLK1 or TLK2. We also treated
mock-transfected KSHV-293 cells with 12-O-tetradecanoyl-
phorbol-13-acetate (TPA), a potent chemical inducer of KSHV
lytic reactivation, as a positive control. RNA was harvested
54 hr posttransfection and real-time quantitative PCR (qPCR)
was performed for three key viral lytic mRNAs: vIL-6, ORF57,
and vGPCR (Figure 2C). TLK2 knockdown cells induced expres-
sion of all three viral lytic mRNAs, to levels fairly similar to those
observed for the TPA-treated sample. The corresponding
western blots that show the protein levels of the targeted genes
are depicted in Figure 2D. To investigate whether depletion of
TLK2 led to an increase in viral genomes, we transfected
KSHV-293 cells with siRNAs against GAPDH, TLK1, or TLK2,
and extracted the total DNA 94 hr posttransfection. Viral
genomes were quantitated by qPCR (Figure 2E). TLK2 siRNA
transfected cells displayed an16-fold increase in viral genome
copy number compared with the GAPDH-depleted cells. Knock-
down of TLK1, TLK2, andGAPDHwas confirmed bywestern blot
analysis (Figure 2F). This demonstrates that knockdown of TLK2
results in increased viral lytic gene expression and increased
viral genome replication.
The Major Viral Lytic Switch Protein, ORF50/RTA,
Is Activated Upon TLK2 Knockdown
The KSHV replication and transcription activator protein (RTA),
encoded by ORF50, plays an essential role in the initiation of viral
lytic gene expression. Since knockdown of TLK2 led to the
expression of viral lytic genes that were regulated by KSHV
ORF50, we wanted to determine whether ORF50 levels were
also increased. To determine whether ORF50 promoter activity
was increased following TLK2 knockdown, we performed a
reporter gene assay using a luciferase reporter gene under the
control of the ORF50 promoter. We transfected 293 cells with
siRNA against GAPDH, TLK1, or TLK2, and then transfected
the cells 24 hr later with an ORF50-promoter luciferase construct
(Damania et al., 2004). Luciferase expression was measured
48 hr posttransfection (Figure 3A). Depletion of TLK2 resultedvier Inc.
Figure 2. TLK2 Plays a Role in KSHV Reactivation
(A) Knockdown of TLK2 reactivates KSHV. KSHV-293 cells were reverse transfected with a final siRNA concentration of 25 nM. A single GAPDH siRNA or a pool of
four siRNAs against TLK1 or TLK2 was used. At 70 hr posttransfection, images were taken on a fluorescent microscope.
(B) siRNAs efficiently knock down the target. Cellular lysates from the samples imaged in Figure 2A were harvested and western blots were performed for TLK1,
TLK2, GAPDH, and the loading control, tubulin.
(C) Viral lytic mRNAs are expressed. KSHV-293 cells were either mock transfected or reverse transfected with 50 nM of the NTC siRNA or the pooled TLK1 or
TLK2 siRNAs. The mock-transfected sample was treated with 25 ng/ml of TPA at the time of transfection. Levels of the viral lytic transcripts vIL-6, Orf57, and
vGPCR were measured by qPCR at 54 hr posttransfection. Values are normalized to the control siRNA.
(D) Western blots were performed for the indicated proteins for the experiment described in (C).
(E) KSHV-293 cells were reverse transfected as described in (C). At 96 hr posttransfection, DNA was harvested and viral load was determined by qPCR. Primers
for Orf57 were used as the indicator of viral genome copies.
(F) Western blots were performed for the indicated proteins to confirm knockdown in the experiment described in (E). In Figure 2 asterisks denote nonspecific
bands. Error bars represent SD from the mean. Data were analyzed using a two-tailed type II Student’s t test for significance. See also Figure S2.
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with the GAPDH- and TLK1-depleted cells. Knockdown of the
targeted proteins was confirmed (Figure 3B). This indicates
that TLK2 knockdown leads to activation of the ORF50 pro-
moter, even in the absence of other viral proteins. Next, we
examined ORF50 transcript levels. KSHV-293 cells were trans-
fected with an NTC siRNA or siRNAs against TLK1 or TLK2. Total
RNAwas harvested 54 hr posttransfection, and qPCR for ORF50
mRNA was performed. As can be seen in Figure 3C, there was
a 12-fold increase in ORF50 mRNA levels when TLK2 siRNA
was transfected into KSHV-293 cells compared with the control
siRNA. Additionally, lytic gene expression of two other viral
genes, K1 and ORF36, was also increased in TLK2 siRNA
transfected KSHV-293 cells (Figure 3D).
Depletion of TLK2 Leads to Complete Viral Reactivation
and Production of Infectious Virus
To test the effect of TLK2 knockdown on overall viral gene
expression, we performed genome-wide viral profiling using
our KSHV qPCR array (Dittmer, 2003). KSHV-293 cells were
transfected with the NTC siRNA or a siRNA targeting TLK1 orCell Host &TLK2. As a positive control for viral reactivation, we treated un-
transfected cells with 0.1 mM sodium butyrate, a known inducer
of KSHV reactivation. Cells were incubated for 96 hr and then
KSHV genome-wide transcription was measured. Similar to
the case with sodium-butyrate-treated cells, when TLK2 was
depleted from the KSHV-293 cells, nearly all of the viral genes
were upregulated, which is indicative of complete viral reactiva-
tion (Figure 4A; see also Figure S3). This was in contrast to the
control siRNA and TLK1 siRNA-treated cells, which showed
minimal levels of upregulated viral transcripts in KSHV-293 cells.
Complete KSHV replication results in virion production and the
release of infectious virions from the cell that can subsequently
infect naive cells. To determine whether TLK2 knockdown led
to the production of infectious virions, we transfected KSHV-
293 cells with siRNAs targeting GAPDH, TLK1, or TLK2. Both
the cell lysates and supernatants were collected 96 hr posttrans-
fection. The lysates were used to perform western blots exam-
ining the expression of two viral lytic proteins (an early lytic
protein [vIL-6] and a late lytic protein [K8.1A]) that were highly
expressed only in the TLK2 siRNA-transfected cells (Figure 4B)
and not in the TLK1 or GAPDH siRNA-transfected cells.Microbe 13, 204–214, February 13, 2013 ª2013 Elsevier Inc. 207
Figure 3. The Major Lytic Switch Protein,
KSHV ORF50/RTA, Is Activated following
TLK2 Knockdown
(A) The KSHV ORF50 promoter is activated by
TLK2 knockdown. HEK293 cells were transfected
with GAPDH siRNA or a pool of TLK1 or TLK2
siRNAs (50 nM) for 24 hr, followed by transfection
with an ORF50 luciferase reporter construct.
Lysate was harvested 48 hr after ORF50-lucif-
erase transfection and a luciferase assay was
performed. Values are normalized to protein levels
determined by Bradford assay.
(B) Western blots were performed for TLK1, TLK2,
and tubulin to confirm knockdown.
(C) Increase in ORF50 mRNA. Levels of ORF50
viral transcript were measured by qPCR as de-
scribed in (C).
(D) Induction of other viral lytic genes. KSHV-293
cells were reverse transfected with GAPDH siRNA
or a pool of TLK1 or TLK2 siRNAs (50 nM) for 96 hr.
Total RNA was harvested and RT-PCR was per-
formed on the RNA (±RT) and PCR products were
run out on agarose gels. In Figure 3 error bars
represent SD from the mean. Data were analyzed
using a two-tailed type II Student’s t test for
significance. M, marker lane.
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cells were clarified to remove cellular debris and then used to
infect naive Vero cells to determine whether infectious virus
was present. The Vero cells were monitored by fluorescence
microscopy for GFP-positive cells, which are indicative of viral
infection. Pockets of GFP-positive cells can clearly be seen in
the Vero cells treated with the supernatants from the TLK2
knockdown KSHV-293 cells (Figure 4C), indicating that infec-
tious virus was produced. We harvested these newly infected
Vero cells and extracted the total intracellular DNA to perform
a viral load assay. In agreement with our other data, naive Vero
cells incubated with the supernatants from the TLK2 knockdown
KSHV-293 cells displayed much higher levels of viral genomes
than cells incubated with the supernatants from the GAPDH
knockdown cells (Figure 4D).
TLK Depletion Can Also Reactivate KSHV from PEL
To examine the effect of TLK knockdown in KSHV-infected B
cells, we transfected BCBL-1 PEL cells with an NTC siRNA or
siRNAs against TLK1 or TLK2. At 120 hr posttransfection, the
cells were harvested and protein lysate was extracted and sub-
jected to western blot analysis against the viral lytic proteins,
vIL-6 and K8.1A. As can be seen in Figure 5A, BCBL-1 cells
transfected with the TLK2 siRNA showed viral reactivation, as
indicated by the increased expression of vIL-6 and K8.1A lytic
proteins compared with the control siRNA-transfected cells.
Cells transfected with TLK1 siRNA also showed a certain degree
of viral reactivation in PEL, but not to the same extent as TLK2
depletion, suggesting that depending on the particular cell
type, one of the two TLK genes may be predominantly involved
in modulating viral latency and suppressing reactivation. To
investigate the effect of TLK2 depletion on a variety of PEL cell
lines, we infected a panel of PEL cells (BC-3, JSC-1, and VG-1)
with either a control lentivirus or one targeting TLK2 for knock-
down. Infections proceeded for 96 hr and then western blots208 Cell Host & Microbe 13, 204–214, February 13, 2013 ª2013 Elsefor vIL-6 were performed on the harvested lysates (Figure 5B).
Viral reactivation was seen in each of the examined PEL cell
lines. These data show that depletion of TLKs in natural KSHV-
infected PEL cells leads to KSHV reactivation.
TLK2 Knockdown Leads to Decreased Phosphorylated
Histone H3 Bound to the ORF50 Promoter
The expression and repression of genes, both cellular and viral,
are tightly controlled by chromatin structure andmodifications. It
was previously shown that TLKs can phosphorylate histone H3
at the serine 10 position (Li et al., 2001). This histonemodification
was shown to modulate transcription (Burkhart et al., 2007; Goto
et al., 1999, Van Hooser et al., 1998; Lefebvre et al., 2002; Maha-
devan et al., 1991). In latently infected cells, the KSHV ORF50
promoter is associated with repressive histone, which is re-
leased upon reactivation (Gu¨nther and Grundhoff, 2010; Toth
et al., 2010). It is possible that TLK2 depletion leads to viral reac-
tivation in KSHV-293 cells, in part because the histone H3 asso-
ciated with the ORF50 promoter is dephosphorylated, leading to
activation and expression of ORF50/RTA.
To determine whether depletion of TLK2 led to less phosphor-
ylated histone H3 associated with the ORF50 promoter,
we performed a chromatin immunoprecipitation (ChIP) assay.
KSHV-293 cells were transfected with either an NTC siRNA or
the TLK2 siRNA and incubated for 96 hr. ChIP analysis was per-
formed using an anti-phospho histone H3 (Ser10) or control
immunoglobulin G (IgG) antibody, and the amount of phosphor-
ylated histone H3 bound to theORF50 promoter was determined
by qPCR. Following TLK2 depletion, there was an 5.5-fold
reduction in the amount of serine 10-phosphorylated histone
H3 associated with the ORF50 promoter compared with the
control siRNA (Figure 5C). We also ran the qPCR reactions on
an agarose gel to visualize the PCR products (Figure 5D).
Because it is possible that the decreased association of phos-
pho-histone H3 with the ORF50 promoter is due to a globalvier Inc.
Figure 4. Genome-wide Upregulation of Viral Transcripts, Induction of Lytic Proteins, and Production of Infectious Progeny Virions following
TLK2 Knockdown
(A) TLK2 knockdown induces KSHV reactivation. KSHV-293 cells were either treated with 0.1 mM sodium butyrate or transfected with 50 nM of a single control
siRNA or siRNA targeting TLK1 or TLK2 for 96 hr. RNA was isolated and a KSHV viral array was performed to determine viral transcript levels. This array has
multiple qPCR primer pairs for each annotated KSHV ORF. A heatmap for the viral array is shown. Higher transcript levels are indicated by red, and lower levels
are indicated by blue. Each primer was scaled independently, such that the median across all experiments for this primer is indicated by white. Genes on the
vertical axis and samples on the horizontal axis were clustered by similarity of their transcription profile using a Euclidian-based distance matrix and Ward’s
algorithm. The corresponding dendrograms (tree) are shown outside the heatmap. The branch length corresponds to the relative similarity of samples and genes,
e.g., induced (NaB) and TLK2 siRNA-treated samples form the right branch and cluster together. Control siRNA and TLK1 siRNA-treated samples form the left
main branch and cluster together.
(B) Viral lytic proteins are expressed. KSHV-293 cells were reverse transfected with GAPDH siRNA or a pool of TLK1 or TLK2 siRNAs (50 nM). Cell lysates were
harvested 96 hr posttransfection and western blots were performed for the lytic proteins vIL-6 and K8.1A; cellular TLK1, TLK2, and GAPDH; and the loading
control, tubulin.
(C) Infectious virus is produced. Cell supernatants were harvested from the same samples as in (B) and used to infect 80,000 Vero cells/well. Images were taken
96 hr postinfection.
(D) Viral load assay. Cell-associated DNAwas harvested from the Vero cells described in (C) at 96 hr postinfection and intracellular viral genome copy number was
determined for the whole cell population. Error bars in Figure 4 represent SD from the mean. Data were analyzed using Student’s t test for significance. See also
Figure S3.
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immunofluorescence assay (IFA) to examine the status of total
phosphorylated histone H3 (Ser10). KSHV-293 cells were
depleted of TLK2 by siRNA or transfected with a control siRNA,
and 48 hr later the cells were stained for pHistone H3 (Ser10).
The overall level of phosphorylated histone H3 (Ser10) wasCell Host &unchanged upon TLK2 knockdown (Figure S4A). This was
confirmed by western blot, because the total levels of histone
H3 and phospho-histone H3 (Ser10) were not altered upon
TLK2 knockdown (Figure S4B). These data show that the viral
reactivation phenotype seen following depletion of TLK2 is
associated with less phosphorylated histone H3 bound to theMicrobe 13, 204–214, February 13, 2013 ª2013 Elsevier Inc. 209
Figure 5. Knockdown of TLKs Leads to
KSHV Reactivation in PEL and Reduction
of Phospho-histone H3 Associated with
the KSHV ORF50 Promoter
A) Depletion of TLKs reactivates KSHV in PEL
cells. BCBL-1 cells were transfected with single
siRNAs (150 mM) against TLK1, TLK2, or an NTC,
and cell lysates were harvested 120 hr post-
transfection. Western blots were performed for the
viral lytic proteins vIL-6 and K8.1A, as well as for
TLK1, TLK2, and tubulin. Asterisk denotes a
nonspecific band.
(B) Reactivation in a panel of PEL lines. BC-3,
JSC-1, and VG-1 cells were infected with lentivirus
expressing either a scrambled control shRNA or
shRNA targeting TLK2. Cell lysates were collected
96 hr postinfection and western blots were per-
formed for vIL-6, TLK2, and tubulin.
(C) ChIP assay. KSHV-293 cells were reverse
transfected with 50 nM of either an NTC siRNA
or a siRNA against TLK2 prior to plating. A
ChIP assay was performed 96 hr posttransfec-
tion as described in the Experimental Proce-
dures using either an antibody against phos-
phorylated histone H3 (Ser10) or mouse IgG.
The level of phospho-histone H3 bound to the
ORF50 promoter was determined by qPCR using
promoter-specific primers. Values are given as the relative enrichment compared with the IgG control. Error bars represent SD from the mean.
(D) Visualization of the qPCR products. PCR products from (C) were run on a 2% agarose gel. See also Figure S4.
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TLKs Modulate Gammaherpesvirus ReactivationORF50 promoter and a subsequent increase in expression of
ORF50/RTA.
TLKs Also Regulate EBV Reactivation from Latency
To determine whether the actions of the TLKs in maintaining
latency are specific to KSHV or also modulate the reactivation
of other related oncogenic gammaherpesviruses, we examined
the effects of TLK depletion on the EBV life cycle. We depleted
TLK1 or TLK2 by siRNA in an EBV-infected gastric cancer cell
line (AGS-EBV; Zhou et al., 2005) and measured the expression
of signature lytic viral mRNAs and proteins (Figures 6A and 6B).
Interestingly, in the case of EBV, TLK1 appears to have the
predominant role in the regulation of EBV reactivation from
latency. As can be seen in Figure 6A, depletion of either TLK1
or TLK2 led to induction of lytic EBV mRNA transcripts, but
knockdown of TLK1 resulted in higher levels of the lytic viral
mRNAs tested. A similar effect was seen at the protein level:
siRNA-mediated knockdown of either TLK1 or TLK2 led to
increased expression of the viral lytic proteins EA-D and EA-R,
with the highest levels seen following TLK1 depletion (Figure 6B).
To ensure that EBV reactivation in our system is specific to the
TLKs, we also knocked down the cellular kinase STK38. Deple-
tion of STK38 in the AGS-EBV cells showed no appreciable reac-
tivation above background (Figure 6C). We next examined
whether the reactivation phenotype observed in the AGS-EBV
cells is also seen in the Burkitt lymphoma cell line, Akata.
Akata-BX1 cells were infected with lentiviruses expressing either
a scrambled small hairpin RNA (shRNA) or a shRNA targeting
TLK1 or TLK2. Cells were infected for 96 hr, at which point cell
lysates were harvested and EBV reactivation was measured by
expression of the viral lytic proteins EA-D and EA-R, as well as
the lytic transactivator protein Zta. Similar to the case with
AGS-EBV cells, knockdown of both TLK1 and TLK2 led to viral210 Cell Host & Microbe 13, 204–214, February 13, 2013 ª2013 Elsereactivation, as shown by increased expression of all three lytic
proteins (Figure 6D). Also, cells that were depleted of TLK1
expressed higher levels of the lytic proteins than those that
had TLK2 knocked down, further suggesting that TLK1 is the
predominant TLK for maintenance of EBV latency and suppres-
sion of reactivation. We also compared the levels of viral reacti-
vation in Akata and Akata-BX1 cells following TLK knockdown
with those observed after treatment with human IgG, a known
inducing agent of reactivation in Akata cells (Figure S5). Collec-
tively, our data indicate that the TLKs play a role in reactivating
not only KSHV but also another gammaherpesvirus, EBV.
DISCUSSION
During KSHV infection, the virus undergoes two different tran-
scriptional programs: latency and lytic replication. Following
primary infection, KSHV can establish latency in most cells,
with only a small proportion of infected cells harboring lytically
replicating virus (Zhong et al., 1996; Dittmer, 2003). Both the
latent and lytic phases of the viral life cycle have been shown
to be important in KSHV-induced malignancies. Essentially all
KS, PEL, and MCD lesions harbor KSHV DNA, and the vast
majority of these are latently infected (Soulier et al., 1995; Dupin
et al., 1999; Parravicini et al., 1997; Staskus et al., 1997; Dittmer,
2011). Latent viral products have been shown to transform cells
and affect cell survival and proliferation, supporting the premise
that latency plays a key role in the generation of KSHV-associ-
ated diseases (reviewed in Ja¨rviluoma and Ojala, 2006). Lytic
proteins also play a role in tumorigenesis via paracrine effects,
because they induce the expression of chemokines and cyto-
kines that promote inflammation, angiogenesis, and proliferation
of neighboring cells (Wang et al., 2004; Ye et al., 2007a; Cai et al.,
1994; Chang et al., 2000; Sodhi et al., 2006).vier Inc.
Figure 6. Knockdown of TLKs Leads to
Reactivation of the Related Gammaherpes-
virus, EBV
(A) EBV lytic mRNAs are expressed upon knock-
down of the TLKs. AGS-EBV cells were reverse
transfected with 50 nM of the NTC siRNA or single
TLK1 or TLK2 siRNAs. Levels of the viral lytic
transcripts BMRF1, BLLF1b, and BCLF1 were
measured by qPCR at 90 hr posttransfection.
Values are normalized to the control siRNA. Error
bars represent SD from the mean.
(B) EBV lytic proteins are induced upon knock-
down of the TLKs. AGS-EBV cells were reverse
transfected with 50 nM of a single siRNA against
TLK1, TLK2, or the NTC, and cell lysates were
harvested 120 hr posttransfection. Western blots
were performed for the EBV lytic proteins EA-D
and EA-R, as well as for TLK1, TLK2, and tubulin.
(C) Reactivation is specific to the TLKs. AGS-EBV
cells were reverse transfected with 50 nM of the
NTC siRNA or a single siRNA targeting TLK1 or
a control kinase, STK38. Cell lysates were har-
vested 96 hr posttransfection and western blots
were performed for EA-D, EA-R, TLK1, STK38,
and tubulin.
(D) Reactivation in Burkitt lymphoma cells. Akata-
BX1 cells were infected with lentiviral particles
expressing either an NTC, TLK1, or TLK2 shRNA.
Cells were harvested 96 hr later and western
blots were performed for the indicated proteins. In
Figure 6, asterisks denote nonspecific bands. See
also Figure S5.
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TLKs Modulate Gammaherpesvirus ReactivationBecause both latent and lytic proteins play key roles in
gammaherpesvirus-associated diseases, it is important to
understand the mechanisms that regulate the two phases of
the viral life cycle. Our kinome screen identified the TLKs as im-
portant regulators of gammaherpesvirus reactivation. Although
we identified other hits in our screen, we validated only TLK2
and none of the other hits. When the TLKs were depleted in cells
harboring latent KSHV or EBV, there was robust reactivation of
the virus, as illustrated by the expression of viral lytic mRNA
and protein, and the production of infectious progeny virions.
In eukaryotic cells, DNA wraps around histones to form nucleo-
somes. The structure of chromatin is a critical factor in the regu-
lation of gene function. Heterochromatin is a tightly packaged
chromatin that has low accessibility to the transcriptional and
replicative machinery and is regarded as functionally inactive,
whereas euchromatin is more loosely packed, which promotes
active transcription of DNA. Posttranslational modifications of
histones, such as acetylation, methylation, and phosphorylation,
regulate chromatin structure (reviewed in Bannister and Kouzar-
ides, 2011). TLK activity is tightly linked to ongoing DNA replica-
tion, and the TLKs play a role in chromatin assembly through
interaction with and phosphorylation of the human chromatinCell Host & Microbe 13, 204–214,assembly factors Asf1a and Asf1b (Sillje´
and Nigg, 2001; Takahata et al., 2009).
The same rules that apply to human
chromosomes hold true for viral epi-
somes. Similarly to the host cell DNA, viral
DNA is chromatinized, and this playsa role in regulating viral gene transcription. Most of the KSHV
and EBV latent episomes are associated with nucleosomes
(Stedman et al., 2004; Gu¨nther and Grundhoff, 2010; Toth
et al., 2010; Chau and Lieberman, 2004; Zhou et al., 2005). Treat-
ment of latently infected cells (in either cell culture or patients)
with histone deacetylase inhibitors stimulates lytic gene expres-
sion, suggesting that heterochromatin promotes the mainte-
nance of latency by suppression of viral lytic genes (Zhou
et al., 2005; Ye et al., 2007b; Krown et al., 2011). The KSHV
ORF50 promoter is partially repressed by the positioning of
a nucleosome over a Sp1 binding site and the transcription start
site (Lu et al., 2003; Ye et al., 2005). Histone H3 is known to be
a phosphorylation target of the TLKs at residue Ser10 (Li et al.,
2001), and histone H3 Ser10 phosphorylation has been shown
to lead to chromatin condensation (Burkhart et al., 2007; Goto
et al., 1999; Van Hooser et al., 1998). Our data show that knock-
down of TLK2 results in decreased association of Ser10-phos-
phorylated histone H3 with the KSHV ORF50 promoter, which
may allow for more ‘‘open’’ and actively transcribed chromatin,
resulting in the reactivation phenotype observed. However, other
mechanisms besides phosphorylation of histone H3 are also
likely to contribute to transactivation of the ORF50 promoter.February 13, 2013 ª2013 Elsevier Inc. 211
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TLKs Modulate Gammaherpesvirus ReactivationIt is also possible that knockdown of TLK2 induces amore global
change in chromatin. This is an area of future study.
Chromatin structure and histone modifications are signifi-
cant factors in determining whether gammaherpesviruses will
remain in their latent phase or reactivate and undergo lytic
replication. Our discovery that the TLKs play a key role in
gammaherpesvirus reactivation may potentially be used in
a therapeutic strategy to treat malignancies associated with
these viruses. The concept of lytic therapy involves inducing
viral reactivation from latency in combination with antiviral
drugs. This was shown for EBV by inducing lytic replication
with the chemotherapeutic drugs doxorubicin and gemci-
tabine, followed by treatment with antiherpesvirus drugs such
as ganciclovir (Feng et al., 2004), and with bortezomib and
radiotherapy for both EBV and KSHV (Fu et al., 2008). Reacti-
vating gammaherpesviruses by depleting the TLKs in com-
bination with drugs such as ganciclovir could prove to be an
effective treatment modality for gammaherpesvirus-associated
malignancies.
EXPERIMENTAL PROCEDURES
Cell Culture and Generation of KSHV-293 Cells
HEK293 and Vero cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM; Cellgro) containing 10% fetal bovine serum (FBS) and 1%
penicillin-streptomycin (PS). PEL cells were grown in RPMI 1640 media
(Cellgro) containing 10% FBS, 1% PS, 0.05 mM beta-mercaptoethanol, and
0.007% sodium bicarbonate. AGS-EBV cells were grown in F-12 media
(GIBCO) containing 10% FBS, 1% PS, and 500 mg/ml G418 as described
previously (Marquitz et al., 2012). Akata cells were maintained in RPMI 1640
media (GIBCO) containing 10% FBS and 1% PS. Akata-BX1 cells were main-
tained in RPMI 1640 media containing 1% PS and 0.5 mg/ml G418 as previ-
ously described (Molesworth et al., 2000). Induction of EBV reactivation was
induced by treatment with 10 mg/ml of anti-human IgG (catalog no. I5260;
Sigma) for 24 hr. KSHV-293 cells were generated by infecting HEK293 cells
with the rKSHV.219 dual reporter virus (a kind gift from J. Vieira; Vieira and
O’Hearn, 2004). KSHV-293 cells were maintained in DMEM media containing
10% FBS, 1% PS, and puromycin (1 mg/ml).
siRNAs and Transfections
All siRNA duplexes were purchased from Dharmacon, except for the TLK2
siRNA used in Figures S2A and S2B, which was purchased from Sigma
(catalog no. SIHK2298). The control siRNAs included GAPDH (catalog no.
D-001140-01), nontargeting siRNA #1 (catalog no. D-001810-01), and UBB
(catalog no. LU-013382). ON-TARGETplus Set of four Upgrade pool of
siRNAs were used for TLK1 (catalog no. LU-004174), TLK2 (catalog no.
LU-005389), and STK38 (catalog no. LU-004674). The target sequences of
the siRNAs are listed in Table S1. Where indicated, single siRNAs from the
set of pooled siRNAs against TLK2 were used. Cells were transfected with
siRNAs using either Dharmacon DharmaFECT1 (HEK293, KSHV-293, and
AGS-EBV cells) or Invitrogen Lipofectamine RNAiMAX (BCBL-1 cells). Where
indicated, fluorescent microscopy images were acquired using a Nikon
Eclipse Ti inverted microscope.
shRNA and Lentivirus
The scrambled control and TLK1 (TRCN0000007057) shRNAs are in the
pLKO.1-puro background and were purchased from Sigma Aldrich. The
TLK2 shRNA was generated by insertion of the hairpin target sequence into
the pLKO.1-puro vector by site-directed mutagenesis using the Quikchange
II XL kit (Agilent Technologies). The shRNA sequences are listed in Table S1.
Lentivirus for each of the shRNAs was produced by using the ViraPower
Lentiviral Expression System (Invitrogen) per the manufacturer’s instructions.
Lentiviral infections were performed by addition of lentivirus and polybrene
(4 mg/ml) to cells in 15 ml conical tubes and spinoculation at 2,500 rpm for
2 hr at 30C as described previously (West and Damania, 2008).212 Cell Host & Microbe 13, 204–214, February 13, 2013 ª2013 ElsesiRNA Screen
For the primary screen, KSHV-293 cells were reverse transfected using
the Dharmacon SMARTpool protein kinase siRNA library (catalog no.
G-003505-10) in a 384-well format purchased by the RNAi Screening Core
of the UNC Lineberger Comprehensive Cancer Center. Each well contained
a pool of four different siRNAs targeting a single gene. The siRNA library
consists of three ‘‘mother plates’’ that were each dispensed into triplicate
‘‘daughter plates’’ using a Biomek FXp Laboratory Automation Workstation
(Beckman Coulter). The control siRNAs GAPDH (catalog no. D-001140-01)
and UBB (catalog no. J-013382-05) were pipetted by hand into the plates.
The reverse transfection was performed in the following manner: DMEM with
no phenol red (GIBCO, catalog no. 31053) was added to the wells of the
daughter plates using a MicroFlo Select dispenser (BioTek), followed by the
addition of the siRNAs so that the final concentration was 25 nM/well. A
DharmaFECT1/DMEMmixture was made and incubated at room temperature
for 5 min and then added to the wells. The plate was manually mixed by gentle
agitation by hand and then spun down and incubated at room temperature for
25 min. While the plate was incubating, KSHV-293 cells were trypsinized,
counted, and resuspended to reach a concentration of 2,500 cells/well. Cells
were seeded on top of the DharmaFECT/siRNA mixture using the MicroFlo
Select dispenser, briefly centrifuged, and incubated at 37C for 70 hr. At
70 hr posttransfection, the plates were imaged using a Cellomics ArrayScan
VTI HCS Reader (Thermo Scientific) to measure GFP and RFP intensity. For
each well, five different fields were imaged and analyzed.
Western Blots
At the indicated times posttransfection, cells were washed with cold PBS and
lysed in RIPA buffer (150 mM NaCl, 1% NP-40, 50 mM Tris pH8, 0.5% sodium
deoxycholate, 0.1% SDS) with protease inhibitor cocktail (Roche) for 30min at
4C. Samples were clarified by centrifugation for 10 min at 8.2 3 g. Protein
amounts were determined by a Bradford assay (BioRad), and equal amounts
of protein were resolved on 10% SDS-PAGE gels and transferred to nitrocel-
lulose membranes. Membranes were blocked for 30 min at room temperature
in either 5% nonfat dry milk (NFDM) or 5% bovine serum albumin (BSA) in
a 13 TBS/0.1% Tween (TBST) solution. Membranes were then incubated
with primary and secondary antibodies. For the antibodies used, see the
Supplemental Experimental Procedures.
Viral Load Assay
To determine the intracellular viral load, cells were harvested at the indicated
time points and DNAwas extracted using the QIAGEN DNeasy Blood & Tissue
Kit according to the manufacturer’s instructions. ORF57 primers were used
to determine viral genomes, and genome copies were quantitated by com-
parison with an ORF57 plasmid-derived standard curve. For viral lytic mRNA
transcription, cells were harvested and RNA was isolated using the QIAGEN
RNeasy Plus Mini Kit followed by treatment with 1 U of RQ1 DNase (Promega)
per mg of RNA for 30 min at 37C. DNase was heat-inactivated at 65C for
10 min. cDNA was reverse transcribed from 100 ng of RNA using MMLV
reverse transcriptase (Invitrogen) and random hexamer primers (Invitrogen)
by incubation at 37C for 60 min followed by heat inactivation at 95C for
5 min. Gene expression levels were determined by real-time qPCR using the
Power SYBR Green PCR mastermix (Applied Biosystems). The qPCR reac-
tions were run on an ABI 7300 machine. Relative fold calculations were deter-
mined by the DDCT method (Dittmer, 2003).
RT-PCR
Total RNA was extracted and converted into cDNA as described above for the
viral load assay. The cDNAwas then used as the template in RT-PCR reactions
using Taq polymerase (QIAGEN). PCR products were then run out on an
agarose gel.
KSHV Infection Assay
KSHV-293 cells were transfected with the indicated siRNAs for 96 hr. Superna-
tants were collected and spun down at 5,000 rpm for 5 min to remove cellular
debris. Polybrene (4 mg/ml) was added to the clarified supernatant and incu-
bated for 10 min at room temperature. The supernatants were then added to
naive Vero cells (80,000 cells/well) in a 12-well plate and spinoculated at
2,500 rpm for 1.5 hr at 30C as previously described (West and Damania,vier Inc.
Cell Host & Microbe
TLKs Modulate Gammaherpesvirus Reactivation2008). Ninety-six hours later, the cells were examined by fluorescent micros-
copy using the Nikon Eclipse Ti inverted microscope for GFP expression, and
intracellular KSHV viral loads were determined by qPCR as described above.
Luciferase Assay
To assay ORF50 activity, 120,000 HEK293 cells/well of a 12-well plate were
reverse transfected with siRNAs against GAPDH, TLK1, or TLK2 at a final
concentration of 50 nM and incubated at 37C for 24 hr. The cells were then
transfected with 2 mg of a KSHV ORF50 promoter luciferase reporter plasmid
(Promega) and incubated for 48 hr at 37C. Cells were harvested and luciferase
activity was measured according to the manufacturer’s instructions.
KSHV Viral Array
KSHV-293 cells were either transfected with the indicated siRNAs or treated
with 0.1 mM sodium butyrate and incubated for 96 hr at 37C. Total RNA
was extracted and treated with DNase as described above for the viral load
assay. cDNAwas reverse transcribed from 10 mg of RNA using the Superscript
II system (Invitrogen) and random hexamer primers (Invitrogen). The reaction
mixture was sequentially incubated at 30C for 15 min, 42C for 15 min,
52C for 15 min, and 70C for 10 min. Following reverse transcription, the re-
maining RNAwas digested by treatment with 1 U of RNaseH for 30min at 37C
and the reaction was quenched by heating to 95C for 5 min. The duplicate
samples were subjected to a KSHV real-time PCR viral array as described
previously (Dittmer, 2003) with the addition of redundant primers, such that
more than one primer pair was used to measure each known viral transcript.
ChIP
KSHV-293cellswereplated at 23106 cells per 10 cmdish and transfectedwith
50 nM of either an NTC siRNA or a siRNA targeting TLK2, and the cells were
incubated for 96 hr posttransfection. The ChIP assay was performed using
the EZ-ChIP kit (catalog no. 17-371; Millipore) per the manufacturer’s instruc-
tions. Immunoprecipitations were performed by addition of either 2 mg of nor-
mal mouse IgG or anti-phospho histone H3 (Ser10, catalog no. CS200553;
Millipore) and incubation overnight at 4C. The amount of serine 10 phosphor-
ylated histone H3 bound to the ORF50 promoter was determined by qPCR
using ORF50 promoter-specific primers (forward: GGTACCGAATGCCACAA
TCTGTGCCCT; reverse: TTGTGGCTGCCTGGACAGTATTCTCAC).
For all the above assays, additional details and primer sequences can be
found in Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.chom.2012.12.005.
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